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a  b  s  t  r  a  c  t
Non-typhoidal salmonellosis is an important zoonotic disease caused by Salmonella enter-
ica.  The aim of this study was to investigate the prevalence of plasmid-mediated quinolone
resistance in Salmonella spp. and its association with ﬂuoroquinolone susceptibility in
Brazil. A total of 129 NTS isolates (samples from human origin, food from animal origin,
environmental, and animal) grouped as from animal (n = 62) and human (n = 67) food were
evaluated between 2009 and 2013. These isolates were investigated through serotyping,
antimicrobial susceptibility testing, and the presence of plasmid-mediated quinolone resis-
tance (PMQR) genes (qnr, aac(6′)-Ib) and associated integron genes (integrase, and conserved
integron region). Resistance to quinolones and/or ﬂuoroquinolones, from ﬁrst to third gen-
erations, was observed. Fifteen isolates were positive for the presence of qnr genes (8 qnrS, 6
qnrB,  and 1 qnrD) and twenty three of aac(6′)-Ib. The conserved integron region was detected
in  67 isolates as variable regions, from ±600 to >1000 pb. The spread of NTS involving PMQR
carriers is of serious concern and should be carefully monitored.© 2015 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).IntroductionFoodborne diseases caused by non-typhoid Salmonella repre-
sent not only an important public health problem, but also
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1517-8382/© 2015 Sociedade Brasileira de Microbiologia. Published by 
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)an economic burden in many  parts of the world. It has been
estimated that the global incidence of gastroenteritis caused
by non-typhoid Salmonella is almost 93.8 million cases per
year with 155,000 deaths.1 Non-typhoidal Salmonella spp. are
zoonotic agents that have been linked to a variety of food
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ources, particularly foods of animal origin, e.g., beef, poultry,
ggs, and dairy products as well as raw fruits and vegetables.2
The emergence and spread of antimicrobial-resistant
almonella spp. originating from food of animal origin has
ecome a serious health hazard worldwide, especially in
eveloping countries.3,4 Antimicrobial-resistant bacteria can
e selected through the therapeutic treatment of infections
aused by susceptible bacterial populations, both in humans
nd animals; many  mechanisms involved in resistance to
uinolones have been studied.5
Quinolones, particularly ﬂuoroquinolones, are among the
ost widely used antibiotics for treating salmonellosis in both
uman and veterinary infections because of their broad spec-
rum in antimicrobial activity.6
Quinolone resistance in Enterobacteriaceae is mostly medi-
ted by point mutations in the quinolone resistance-
etermining regions (QRDR) of the DNA gyrase and topoi-
omerase IV genes, leading to target modiﬁcation. Plasmid
ediated Quinolone Resistance (PMQR) has emerged in
almonella spp. and in other Enterobacteriaceae with increasing
revalence.7 This resistance involves efﬂux pump mecha-
isms and the more  recently discovered target protection
echanisms controlled by the qnr genes. Enzymatic modiﬁca-
ions encoded by the aac(6′)Ib-cr gene have also been found to
ontribute to the drug resistance of this antimicrobial class.8
The aim of this study was to identify the occurrence
f some PMQR in Salmonella spp. isolated from animal and
uman origin sin Brazil between 2009 and 2013.
aterials  and  methods
 total of 129 Salmonella spp. isolates with resistance to
uinolone and/or ﬂuoroquinolone were evaluated. Of this
otal, 51.9% (67/129) were from human clinical isolates, 30.2%
39/129) from food products for human consumption (beef,
ggs, and milk), 7.1% (9/129) from food of animal origin for
uman consumption (poultry, swine, and cattle), and 10.8%
14/129) from environmental samples (water, drag swabs). The
trains identiﬁed were stored in phosphate-buffered agar and
ent to the National Reference Laboratory of Enteric Diseases
LRNEB/IOC/RJ) between 2009 and 2013.
ntigenic  characterization
almonella serotypes were determined by slide agglutination
ccording to the Kauffmann–White scheme using O and H
ntisera. All antisera used for serological determination were
repared in the LRNEB/IOC/RJ.
ntimicrobial  susceptibility
he resistance proﬁles obtained were conﬁrmed by the disk
iffusion test according to CLSI (2013/2014) using representa-
ives of the quinolone class (OXOID) for human and veterinary
herapeutic use such as Nalidixic Acid 30 g, Ciproﬂoxacin
 g, Enroﬂoxacin 5 g, Oﬂoxacin 5 g, and Levoﬂoxacin 5 g;
acterial suspensions (0.5 Mac  Farland scale) were distributed
hroughout the surface of plates containing Mueller Hintono l o g y 4 7 (2 0 1 6) 196–201 197
agar (OXOID). Discs were deposited on the surface of the cul-
ture medium, which already contained the inoculum. After
incubation for 24 h at 35 ◦C, the diameters of inhibition zones
formed around the discs were observed and measured in
millimeters. The interpretation of results for assignment of
the categories of susceptible, intermediate, and resistant was
according to CLSI (2013). Quality control was performed in par-
allel by testing Escherichia coli ATCC 25922, Staphylococcus aureus
ATCC 25923, and Pseudomonas aeruginosa ATCC 27853.
MIC determinations were performed in 96-well
microplates for Nalidixic Acid (SIGMA), Ciproﬂoxacin (SIGMA),
Enroﬂoxacin (SIGMA), Levoﬂoxacin (SIGMA), and Oﬂoxacin
(SIGMA) according to the CLSI (2013) broth microdilution
assay. MIC was deﬁned as the lowest concentration of drug
that inhibits visible growth after 24 h of incubation at 37 ◦C.
Bacterial suspensions grown at 37 ◦C in BHI broth (OXOID) up
to in the concentration at 0.5 of the MacFarland scale that
were transferred to BHI broth and plates containing different
concentrations of antimicrobials were incubated at 37 ◦C for
24 h. Quality control was performed for every determination
by testing E. coli ATCC 25922, S. aureus ATCC 29213, and P.
aeruginosa ATCC 27853.
Detection  of  PMQR
Total DNA was extracted using the DNEASY Tissue Qiagen® kit
and its concentration was measured using the Nanodrop spec-
trophotometer (ND-1000 Uniscience). The studied genes were
detected by PCR ampliﬁcation using the primer sequences
presented in Table 1. The qnrA, qnrB, and qnrS genes were
ampliﬁed through multiplex PCR reactions; the rrs gene was
used as the reaction control. The qnrC, qnrD, aac(6′)-Ib, inte-
grase, and variable integron region genes were ampliﬁed by
simplex PCR.
Positive and negative controls were included in each PCR
reaction. Ampliﬁed products were identiﬁed by  their molecu-
lar weights after electrophoresis on 1.0% agarose gels at 180 V
for 90 min  and staining with ethidium bromide.
Results
Altogether, 26 different Salmonella serovars were identiﬁed.
The predominant serovar was Salmonella Typhimurium (48.8%,
63/129) followed by Salmonella Enteritidis (19.4%, 25/129). The
prevalent serovars associated with resistance to quinolones
are presented in Table 2.
The highest incidence of resistant isolates was observed
in 2012 (88/129), followed by 2011 (16/129). Most isolates were
isolated in 2012.
Among these 129 isolates that were previously resistant
to Nalidixic Acid, 5 were sensitive to all tested quinolones
(including Nalidixic Acid), 55 (42.6%) were resistant to
Ciproﬂoxacin, 63 (48.8%) to Enroﬂoxacin, 51 (39.53%) to
Oﬂoxacin, and 48 (37.2%) to Levoﬂoxacin through the disc dif-
fusion test.
The broth microdilution test identiﬁed 47 (36.4%) isolates
with decreased susceptibility to Ciproﬂoxacin (MICs between
0.125 mg/mL  and 0.5 mg/mL), 26 (20.1%) to Enroﬂoxacin, 8
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Table 1 – Sequence of oligonucleotide primers used in this study.
Primers Primer sequences (5′-3′) Target gene Amplicon size (bp) Reference
QnrA-F ATTTCTCACGCCAGGATTTG
qnrA 516
Jacoby
et  al.9QnrA-R GATCGGCAAAGGTTAGGTCA
QnrB-F GATCGTGAAAGCCAGAAAGG
qnrB 469
Jacoby
et  al.9QnrB-R ACGATGCCTGGTAGTTGTCC
QnrC-F GGGTTGTACATTTATTGAATCG
qnrC 307
Kim
et  al.8QnrC-R CACCTACCCATTTATTTTCA
QnrD-F CGAGATCAATTTACGGGGAATA
qnrD 582
Cavaco
et  al.10QnrD-R AACAAGCTGAAGCGCCTG
QnrS-F ACGACATTCGTCAACTGCAA
qnrS 417
Jacoby
et  al.9QnrS-R TAAATTGGCACCCTGTAGGC
AAC(6′)-Ib-F TATGAGTGGCTAAATCGAT aac(6′)-
Ib
482
Park
et  al.11AAC(6′)-Ib-R CCCGCTTTCTCGTAGCA
Integrase-F CCTCCCGCACGATGATC
Integrase 250
Peirano
et  al.12Integrase-R TCCACGCATCGTCAGGC
Integron-3 AAGCAGACTTGACCTGA
Integron Variable
Peirano
et  al.13Integron-5 GGCATCCAAGCAGCAAG
Table 2 – Distribution of quinolone-resistant Salmonella spp. serovars isolated from food chain diseases.
Salmonella
Serotype
Year Number  of NTSa isolated from
Human Food Environment Animal Total
S. Tiphymurium
2013  2 – – – 2
2012 24 14 1 1 40
2011 7 2 2 – 11
2010 – 4 – 1 5
2009 2 2 1 1 6
S. Enteritidis
2013  3 – – – 3
2012 20 1 – – 21
2009 1 – – – 1
S. Muenchen
2012  2 1 – – 3
2011 – 1 – – 1
S. Saintpaul 2012 1 – – 2 3
S. Infantis
2012  1 – 1 – 2
2010 – 1 – – 1
S. Heidelberg
2012  – 2 – – 2
2011 – – – 1 1
Others
2013 1 – – – 1
2012 3 8 6 – 17
2011 – 1 1 1 3
2010 – 1 1 2 4
2009 – 1 – 2 3
Total 67 39 14 32 152a Non-typhoid Salmonella.
(6.2%) to Levoﬂoxacin, and 12 (9.3%) to Oﬂoxacin (MICs
between 0.5 mg/mL  and 1 mg/mL). Seventy-three (56.6%)
isolates were resistant to Ciproﬂoxacin, 83 (64.3%) to
Enroﬂoxacin, 44 (34.1%) to Oﬂoxacin, and 39(30.2%) to Lev-
oﬂoxacin. A total of 124 (96.1%) were resistant to Nalidixic
Acid. The decreased susceptibility breakpoint to Nalidixic Acid
is not reported by CLSI (2013).
The resistance proﬁle obtained with the microdilution
test showed that 37 (28.7%) isolates were resistant to all
tested quinolones; 30 (23.2%) were resistant to Ciproﬂoxacin,
Enroﬂoxacin, and Nalidixic Acid; 16 (12.4%) were resistant to
Enroﬂoxacin and Nalidixic Acid; 2 (1.5%) were resistant to
Ciproﬂoxacin and Nalidixic Acid; and 39 (30.2%) were resistantto Nalidixic Acid only. The detection of PMQR was showed in
the Table 3.
The qnr genes were detected in 15 out of the 129 (11.6%)
available Salmonella spp. isolates. Among these positive iso-
lates, 6 contained the qnrB gene, 8 the qnrS gene, and 1
the qnrD gene (Table 3). These strains were recovered from
human samples (n = 10), food from animal origin (n = 3), envi-
ronmental samples (n = 1), and animal samples (n = 1). Seven
different serotypes were identiﬁed with qnr genes. The most
qnr-positive prevalent serovar was S. Typhimurium followed
by S. Saintpaul and S. Livingstone. The qnrS was the most fre-
quent qnr variant observed. None of the isolates presented the
qnrA or qnrC genes. Three qnr-positive isolates presented the
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Table 3 – Quinolone susceptibility of qnr-positive isolates.
Isolate Source PMQR Integrona MIC (g/mL)
Cip Nal Eno Lvx Oﬂ
S. Typhimurium H qnrB
aac(6′)-Ib
–  ≥2 ≥128 ≥4 ≥2 ≥4
S. Typhimurium H qnrB
aac(6′)-Ib
±900 bp ≥2 ≥128 ≥4 ≤0.06 ≤0.25
S. Typhimurium H qnrB – ≥2 ≥128 ≥4 ≥2 ≥4
S. Typhimurium H qnrB >1000 bp ≤0.5 ≥128 ≤1 ≤0.06 ≤0.06
S. Typhimurium F qnrS – ≤0.5 ≤64 ≤2 ≤0.06 ≤0.06
S. Typhimurium F qnrD – ≤0.03 ≤32 ≤0.06 ≤0.06 ≤0.06
S. Saintpaul A qnrS
aac(6′)-Ib
±900 bp ≤0.5 ≥128 ≤0.5 ≤0.06 ≤0.06
S. Saintpaul H qnrS – ≤0.5 ≥128 ≥4 ≤0.06 ≤0.12
S. Muenchen2b H qnrS – ≤0.5 ≤32 ≤2 ≤0.06 ≤0.06
S. Livingstone F qnrS – ≤0.5 ≥128 ≥4 ≤0.06 ≤0.06
S. Orion E qnrS – ≤0.5 ≥128 ≤2 ≤0.06 ≤0.06
S. Panama H qnrS – ≤1 ≤64 ≤2 ≤0.06 ≤0.06
S. Enteritidis H qnrB ±800 bp ≤0.25 ≥128 ≤1 ≤0.06 ≤0.06
S. ent.  subspent. H  qnrB >1000 bp ≤1 ≥128 ≤2 ≤0.06 ≤0.25
S. Typhimurium2 H aac(6′)-Ib – ≥2 ≥128 ≥4 ≤2 ≤2
S. Typhimurium3 F aac(6′)-Ib – ≥2 ≥128 ≥4 ≤2 ≤2
S. Typhimurium E aac(6′)-Ib ±900 bp ≥2 ≥128 ≥4 ≤2 ≤2
S. Typhimurium A aac(6′)-Ib ±900 bp ≥2 ≥128 ≥4 ≤2 ≤2
S. Typhimurium H aac(6′)-Ib ±900 bp ≥2 ≥128 ≥4 ≥4 ≥4
S. Typhimurium F aac(6′)-Ib – ≥2 ≥128 ≥4 ≥4 ≥4
S. Typhimurium F aac(6′)-Ib ±900 bp ≥2 ≥128 ≥4 ≤1 ≤1
S. Typhimurium H aac(6′)-Ib ±800 bp ≤1 ≥128 ≥4 ≥4 ≤2
S. Typhimurium H aac(6′)-Ib >1000 bp ≤0.25 ≥128 ≤0.25 ≤0.12 ≤0.12
S. Enteritidis H aac(6′)-Ib – ≤0.5 ≥128 ≤2 ≤0.12 ≤0.12
S. Enteritidis H aac(6′)-Ib ±800 bp ≥2 ≥128 ≥4 ≤1 ≤1
S. Give H aac(6′)-Ib – ≥2 ≤64 ≥4 ≤1 ≤2
S. Hadar F aac(6′)-Ib – ≤0.5 ≥128 ≤2 ≤0.06 ≤0.06
S. Infantis E aac(6′)-Ib – ≤0.25 ≤8 ≤0.06 ≤0.06 ≤0.06
S. Muenchen F aac(6′)-Ib ±600 bp ≤0.5 ≤32 ≤2 ≤0.06 ≤0.06
S. Montevideo E aac(6′)-Ib – ≤0.5 ≤32 ≤1 ≤0.06 ≤0.06
S. Saintpaul A aac(6′)-Ib ±800 bp ≤0.5 ≥128 ≤1 ≤0.06 ≤0.06
H, human; F, food; E, environment; A, animal; CIP, ciproﬂoxacin; NAL, nalidixic acid; ENO, enroﬂoxacin; LVX, levoﬂoxacin; OFL, oﬂoxacin; MIC,
minimal inhibitory concentration; DD, diffusion disc.
a Variable region.
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Plasmid-mediated quinolone resistance in Salmonellab Isolate quantity.
ac(6′)-Ib in association: two S. Typhimurium and one S. Saint-
aul. The two Salmonella ser. Typhimurium were resistant to
ll tested quinolones/ﬂuoroquinolones by the broth microdi-
ution assay at the highest concentration.
The aac(6′)-Ib gene was prevalent in 12 out of the 20 qnr-
egative isolates of S. Typhimurium. The source of isolation
as higher in human strains (8/20), followed by foodborne
ources (7/20). Eleven isolates were resistant to all tested
uinolones (Table 3).
Fourteen isolates that were PMQR positive presented the
onserved integron region; two isolates presented both qnr and
ac(6′)-Ib genes (Table 3).
Sixty-seven isolates showed the conserved integron region
ith only the variable region, from 600 to 1000 bp (data not
hown). The S. Typhimurium serovar was the most frequent
39/67) with the conserved region of class 1 integron and the
ariable regions between ±900 pb and >1000 pb as the most
bserved. This gene was mostly identiﬁed in human samples
38/67) followed by food samples (15/67).Discussion
The high prevalence of antimicrobial-resistant Salmonella
has been a serious concern for public health over the
past decade.13,14 Fluoroquinolones are important in treat-
ing serious infections caused by Salmonella spp. resistance
to Nalidixic Acid increased signiﬁcantly in recent years,
but high-levels of resistance to ﬂuoroquinolones are, so far,
rare.15,16
Mutations in the quinolone resistance-determining region
(QRDRs) of the gyrA and parC genes alter the DNA-gyrase bind-
ing sites of these antibiotics and can result in resistance to
quinolones. In Salmonella spp., these mutations are related to
Nalidixic acid (NAL) resistance and reduced susceptibility to
17,18spp. has important public health implications. The acqui-
sition of PMQR genes leads to decreased susceptibility to
 i c r o
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ﬂuoroquinolones, accelerating the selection of
ﬂuoroquinolone-resistant mutants.19 Moreover, interac-
tions between mutations in the QRDR and PMQR genes can
result in high ﬂuoroquinolones MIC.20
In the present study, the phenotypic tests and detection
of plasmid-mediated quinolone resistance by molecular basis
among strains isolated from food of animal origin (n = 62) and
human samples (n = 67), between 2009 and 2013 (6 in 2013, 88
in 2012, 16 in 2011, 10 in 2010, and 9 in 2009), were investi-
gated. High prevalence of resistance to ﬂuoroquinolone was
identiﬁed through the disc diffusion and broth microdilution
tests (56.6% resistance to Ciproﬂoxacin, 64.3% to Enroﬂoxacin,
34.1% to Oﬂoxacin, and 30.2% to Levoﬂoxacin). Similar results
are reported in others studies in Asia, Europe, and North
America.7
The discrepancies between disk diffusion and broth
microdilution results indicate that although the disk diffusion
method is an effective screening test, it does not accurately
identify all resistant proﬁles.
A high prevalence of isolates carrying PRQM genes was
reported in the present evaluation (23%, 35/152). Although
most of the isolates were derived from human samples (51.4%,
18/35), other sample sources also have roles as carriers of
quinolone resistance genes in plasmids (10/35 from food of
animal origin, 4/35 from environmental samples, and 3/35
from animal samples).
The majority of isolates exhibiting PMQRS genes were
obtained in 2012; only one foodborne S. Typhimurium isolate
presented aac(6′)-Ib in 2010. This result is explained not only
by the high index of isolates that were resistant to quinolones
in this period but also by the storage process (nutrient phos-
phate agar) that can lead to loss of mobile genetic elements in
older strains.
The most prevalent serovar associated with the presence
of PMQR genes was Salmonella ser. Typhimurium (18/35). The
importance of this serovar in the dissemination of these resis-
tance genes is evident in all types of samples. Other serovars
such as Salmonella ser. Enteritidis, Salmonella ser. Muenchen,
and Salmonella ser. Saintpaul were also important in spreading
PMQR genes in the studied period.
The qnrS, qnrB, and qnrD genes were detected in the
present study. The incidence of these genes has been reported
worldwide.16,21–23 In Brazil the detection of qnr genes was pre-
viously reported by Ferrari et al.17 where were identiﬁed one
S. Enteritidis qnrA positive and one S. Corvalis qnrS positive
in chicken sample.
These genes confer low-level resistance to ﬂuoro-
quinolones and facilitate the development of mutations
in its gyrA QRDR region, a region involved in quinolones
resistance mechanisms.18,24 Nevertheless, some authors
state that the presence of the qnr genes may lead to increased
ﬂuoroquinolone resistance (Ruiz et al., 2012).25 The involve-
ment of plasmid genes in the resistance to ﬂuoroquinolones
is not as well-known as that of other resistance mechanisms.9
The aac(6′)-Ib-cr gene encodes an acetyl transferase that
is responsible for phenotype resistance to aminoglycoside
and Ciproﬂoxacin (norﬂoxacin). It was originally reported in
2003 in an E. coli clinical isolate collected in Shanghai, China,
and later described among various enterobacteria in sev-
eral countries from Asia, North America, and Europe.7 The b i o l o g y 4 7 (2 0 1 6) 196–201
aac(6′)-Ib gene was found in 23 out of the 129 evaluated iso-
lates. Among those 23, two isolates corresponded to Salmonella
Typhimurium strains with the qnrB and aac(6′)-Ib genes, iso-
lated from human samples. The qnrS and aac(6′)-Ib genes
were detected in Salmonella Saintpaul. Nevertheless, the emer-
gence of the aac(6′)-Ib-cr gene among NTS is of serious concern
because the decreased susceptibility to ﬂuoroquinolones from
the expression of the aac(6′)-Ib-cr genes is plasmid-mediated
and therefore, mobile, and could spread through horizontal
transmission to other susceptible isolates in the community.
Although some authors recognize that the location of the
aac(6′)-Ib gene is mostly in class1 integrons, the absence
of the integron gene in all positive aac(6′)-Ib strains is
controversial.19,26 In this study, 11 aac(6′)-Ib positive isolates
showed the integron region, demonstrating a signiﬁcant cor-
relation between these genes.
A high prevalence of isolates with integron genes was iden-
tiﬁed (71/152) with variable regions, from ±600 to >1000 pb. The
occurrence of class 1 integrons with gene cassettes of differ-
ent organizations related to antimicrobial resistance suggests
genetic evolution and demonstrates the role of integrons in
the dissemination of antimicrobial resistance across microbial
communities.27
In conclusion, plasmid-mediated quinolone resistance in
Salmonella spp. has important public health implications. We
report 15 qnr-positive (8 qnrS, 6 qnrB, and 1 qnrD) and 23
aac(6′)-Ib positive Salmonella spp. strains. The conserved inte-
gron region was detected in 67 isolates with variable regions,
from ±600 to >1000 pb. Fluoroquinolones are commonly used
to treat adults with invasive illness or other serious infections
caused by Salmonella species. The surveillance and monitoring
over the spread of PMQR in Salmonella spp. is essential for the
public health control of NTS.
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